MARATTO

article · Malaria Journal

Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo

Abstract

SLDPQ and G6PD status did not compromise posttreatment plasma folate concentrations in young children with acute uncomplicated falciparum malaria, providing additional evidence of SLDPQ safety and supporting its use without G6PD testing. Trial registration The trial is registered, reference number ISRCTN11594437.

Research topics

  • Pharmacological Effects and Toxicity Studies
  • HIV/AIDS drug development and treatment
  • Hemoglobinopathies and Related Disorders

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12936-025-05567-4

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.